The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1113-1121

  Kemball, Christopher C ^a,c   Pack, Christopher D ^a   Guay, Heath M ^b   Li, Zhu Nan ^a   Steinhauer, David A ^a   Szomolanyi Tsuda, Eva ^b   Lukacher, Aron E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; IMMUNOGLOBULIN ANTIBODY; HLA ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRIC POTENTIAL; FEMALE; HOSPITAL SERVICE; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; POLYOMA VIRUS; PRIORITY JOURNAL; SECRETORY CELL; VIRUS INFECTION; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; CHRONIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; VIROLOGY;

ANIMALS; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS;

EID: 34548755703     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1113     Document Type: Article

References (71)

1. + T-cell response. Nat. Rev. Immunol. 4: 595-602.
2. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
3. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
4. + T cell memory. Science 297: 2060-2063.
5. + T lymphocytes. Nature 421: 852-856.
6. +-T-cell-deficient mice. J. Virol. 76: 12388-12393.
7. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62: 2102-2106.
8. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353: 180-184.
9. + T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand. J. Immunol. 40: 373-382.
10. Hou, S., X. Y. Mo, L. Hyland, and P. C. Doherty. 1995. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J. Virol. 69: 1429-1434.
11. + T cells. Immunol. Cell Biol. 67: 413-420.
12. + T cells. J. Immunol. 144: 3980-3986.
13. + T cells in cytotoxic T lymphocyte responses against vaccinia virus. J. Immunol. 142: 270-273.
14. Buller, R. M., K. L. Holmes, A. Hugin, T. N. Frederickson, and H. C. Morse, III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328: 77-79.
15. Marzo, A. L., V. Vezys, K. D. Klonowski, S. J. Lee, G. Muralimohan, M. Moore, D. F. Tough, and L. Lefrançois. 2004. Fully functional memory CD8 T cells in the absence of CD4 T cells. J. Immunol. 173: 969-975.
16. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
17. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
18. + T cells during viral infection: correlation with stable memory development. J. Gen. Virol. 83: 2123-2133.
19. Fuller, M. J., A. Khanolkar, A. E. Tebo, and A. J. Zajac. 2004. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172: 4204-4214.
20. + T cells. J. Exp. Med. 184: 863-871.
21. + T cell numbers are maintained during γ-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15565-15570.
22. b-/- mice. J. Gen. Virol. 84: 337-341.
23. Rowe, W. P. 1961. The epidemiology of mouse polyoma virus infection. Bacteriol. Rev. 25: 18-31.
24. Freund, R., T. Dubensky, R. Bronson, A. Sotnikov, J. Carroll, and T. Benjamin. 1992. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 191: 724-731.
25. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181: 1683-1692.
26. 2- Microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis. Virology 252: 275-284.
27. k-restricted epitope in the middle T protein. J. Immunol. 160: 1724-1734.
28. + T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193: 595-606.
29. + T cell responses during a persistent virus infection. J. Immunol. 174: 7950-7960.
30. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269.
31. -/- double knockout mice. Int. J. Cancer 67: 405-408.
32. Berke, Z., and T. Dalianis. 2000. Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system. Adv. Cancer Res. 79: 249-276.
33. Li, Z. N., S. N. Mueller, L. Ye, Z. Bu, C. Yang, R. Ahmed, and D. A. Steinhauer. 2005. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity. J. Virol. 79: 10003-10012.
34. Blasco, R., and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158: 157-162.
35. + T cells differ for acute and persistent phases of polyoma virus infection. J. Immunol. 176: 1814-1824.
36. Guay, H. M., L. Panarey, A. J. Reed, and A. J. Caton. 2004. Specificity-based negative selection of autoreactive B cells during memory formation. J. Immunol. 173: 5485-5494.
37. Tyznik, A. J., J. C. Sun, and M. J. Bevan. 2004. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199: 559-565.
38. + T cells in major histocompatibility complex class II-deficient mice. Science 253: 1417-1420.
39. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540-547.
40. Szomolanyi-Tsuda, E., and R. M. Welsh. 1996. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J. Exp. Med. 183: 403-411.
41. Szomolanyi-Tsuda, E., J. D. Brien, J. E. Dorgan, R. L. Garcea, R. T. Woodland, and R. M. Welsh. 2001. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 280: 160-168.
42. Szomolanyi-Tsuda, E., J. D. Brien, J. E. Dorgan, R. M. Welsh, and R. L. Garcea. 2000. The role of CD40-CD154 interaction in antiviral T cell-independent IgG responses. J. Immunol. 164: 5877-5882.
43. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
44. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
45. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
46. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
47. Radziewicz, H., C. C. Ibegbu, M. L. Fernandez, K. A. Workowski, K. Obideen, M. Wehbi, H. L. Hanson, J. P. Steinberg, D. Masopust, E. J. Wherry, et al. 2006. Liver infiltrating lymphocytes in chronic human HCV infection display an exhausted phenotype with high PD-1 and low CD127 expression. J. Virol. 81: 2545-2553.
48. + T lymphocytes in the liver. J. Immunol. 178: 2714-2720.
49. Sarawar, S. R., B. J. Lee, S. K. Reiter, and S. P. Schoenberger. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98: 6325-6329.
50. + T cells after acute infection. Nat. Immunol. 5: 927-933.
51. Wherry, E. J., D. L. Barber, S. M. Kaech, J. N. Blattman, and R. Ahmed. 2004. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 101: 16004-16009.
52. Becker, T. C., E. J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195: 1541-1548.
53. + cells. J. Exp. Med. 195: 1523-1532.
54. + T cells. J. Exp. Med. 195: 1515-1522.
55. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrançois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
56. + T cell without effector differentiation. Proc. Natl. Acad. Sci. USA 103: 19454-19459.
57. Berke, Z., T. Wen, S. Jin, G. Klein, and T. Dalianis. 1995. Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice. Virology 212: 268-271.
58. Szomolanyi-Tsuda, E., and R. M. Welsh. 1998. T-cell-independent antiviral antibody responses. Curr. Opin. Immunol. 10: 431-435.
59. Oldstone, M. B. 2006. Viral persistence: parameters, mechanisms and future predictions. Virology 344: 111-118.
60. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
61. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282-287.
62. Kamperschroer, C., J. P. Dibble, D. L. Meents, P. L. Schwartzberg, and S. L. Swain. 2006. SAP is required for Th cell function and for immunity to influenza. J. Immunol. 177: 5317-5327.
63. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
64. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227.
65. + T cell responses. Nat. Immunol. 3: 189-195.
66. Byers, A. M., N. P. Andrews, and A. E. Lukacher. 2006. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection. J. Immunol. 176: 6121-6129.
67. + memory T cells. Immunol. Rev. 211: 146-153.
68. Jelley-Gibbs, D. M., D. M. Brown, J. P. Dibble, L. Haynes, S. M. Eaton, and S. L. Swain. 2005. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J. Exp. Med. 202: 697-706.
69. Zammit, D. J., D. L. Turner, K. D. Klonowski, L. Lefrançois, and L. S. Cauley. 2006. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24: 439-449.
70. + T cells. J. Immunol. 173: 2217-2221.
71. + T cells in the absence of tumor-antigen vaccination. Proc. Natl. Acad. Sci. USA 98: 10811-10816.